Details of the Drug

General Information of Drug (ID: DMTTXCF)

Drug Name

ABC008

Indication

Disease Entry	ICD 11	Status	REF
Inclusion body myositis	4A41.2	Phase 2/3	[1]
------------------------------------------------------------------------------------

Drug Type

Monoclonal antibody

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Killer cell lectin-like receptor subfamily G member 1 (KLRG1)	TT299E6	KLRG1_HUMAN	Not Available	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT05721573) A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of ABC008 in the Treatment of Subjects With Inclusion Body Myositis. U.S.National Institutes of Health.
2	Clinical pipeline report, company report or official report of Abcuro